PLENARY LECTURE

Melanie Anderson, PhD

Principal Scientist @ Merck

Merck's Strategy Around Decentralized Trials, Bioanalytical Sampling & Logistics

 PLENARY LECTURE

Bhagwat Prasad, PhD

Principal Investigator, Associate Professor @ Washington State University

Quantitative Mass Spectrometry-based Multi-omics for Drug Development and Precision Medicine

PLENARY LECTURE

Zhengyin Yan, PhD

Distinguished Scientist @ Genentech

The Dynamic Free Fraction: Concept, Methodology and Use in Clearance Predictions

Jessica Weaver, PhD

Product & Development Team @ LifeNet Health

Edward L. LeCluyse, PhD

Chief Scientist, LifeSciences Division, Institute of Regenerative Medicine @ LifeNet Health

A Novel All Human Hepatice Cell-Based Tri-Culture System for Preclinical Drug Development

Karan Agrawal, PhD

Scientist, Bioanalytical Discovery & Development @ Janssen Research & Development

Evaluating a Hybrid LC-MS/MS Approach for the Quantification of siRNA Analytes

Saravanan Ayyadurai, PhD

Senior Scientist, Global DMPK @ Takeda

NanoString-based High Throughput MicroRNA Biomarker Assay Development

Joe Cannon, PhD

Scientific Associate Director @ Bristol Myers Squibb

Investigating Permeability of Heterobifunctional Protein Degraders

Tom Chan, PhD

Senior Principal Scientist @ Boehringer Ingelheim

Characterization of Divergent Metabolic Pathways in Elucidating an Unexpected, Slow-Forming, and Long Half-Life Major Metabolite of Iclepertin

 Hao Yang, PhD

Product Application Specialist, Chromatography & MS Division @ ThermoFisher Scientific

Sensitive Quantitation of Antisense Oligonucleotides in Human Plasma Using Triple Quadruple & HR Orbitrap based MS Methods

Heather Cohen, PhD

Senior Director, Translational Sciences @ Bicycle Therapeutics

Translating Preclinical Findings Into Clinical Biomarker Assays To Support Phase I/II Study of BT7480, A Bicycle Tumor-Targeted Immune Cell Agonist^TM

Upendra Dahal, PhD

Senior Principal Scientist @ Amgen

ADME Properties of SOTORASIB, a Covalent Drug for Treatment of KRAS G12C Addicted Tumors

William Fitch, PhD

Drug Metabolism, Bioanalysis & Mass Spectrometry Consultant @ Stanford University

Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans. A Unique Challenge for MIST Assessment

Sarah Lloyd, PhD

Postdoctoral Fellow, ECM & Fibrosis @ AbbVie

Development of a Targeted, LC-MS Assay to Investigate Collagen Crosslinking Dynamics in IPF Phatogenesis

Anette Karle, PhD

Senior Principal Scientist Immunogenicity @ Novartis (Switzerland)

MAPPs Assay and Key Applications at Novartis

Dieter Lang, PhD

R&D Pharmaceuticals, In Vitro ADME & IC @ Bayer AG, Germany

Unusual In Vivo Metabolism of Nifurtimox

Steven Louie, PhD

Associate Director @ Moderna Therapeutics

Developing Efficacious Preclinical PK/PD strategies for Bifunctional Targeted Protein Degrader (TPD) Towards Non-Small Cell Lung Cancer (NSCLC)

Suresh Paddigari, PhD

Team Lead @ Moderna

RT-qPCR Method Development and Validation for mRNA Analysis

Lori Payne, PhD

Executive Director of Business Development @ Alturas Analytics

Space - The Final Microsampling Frontier

Edward Price, PhD

Senior Scientist II, DMPK-BA @ AbbVie

Revealing the Absorption Intricacies of bRo5s and PROTACs Through a Fresh Perspective on Assyas and Novel Physiochemical Trends

Akshaya Ramesh, PhD

Principal Bioinformatics Scientist @ Genentech

Mass Spectrometry CSF Proteomics & Single-Cell Sequencing to Identify Novel Biomarkers in Multiple Sclerosis

Simone Schadt, PhD

Head of ADME @ Roche, Basel

Oxidation-Reduction Equilibirum of Thiol-Containing Drugs and Metabolites

Dhaval K. Shah, PhD

Associate Professor @ SUNY Buffalo School of Pharmacy and Pharmaceutical Sciences

Mathematical Models to Characterize the Absorption, Distribution, Metabolism, and Excretion of Protein Therapeutics

Arkadeep Sinha, PhD

Associate Director of Bioanalytical Sciences @ Upstream Bio

DChasing the Matrix Interference in a Bispecific ADA Assay - Divergent Target Interference Based on a Patient Geography

Qin Sun, PhD

Therapeutic Biologics Program, Biologics Lead @ OCP, CDER, US Food and Drug Administration

Drug-Drug Interaction Assessment for Therapeutic Proteins

Yuting Wang, PhD

Senior Scientist (DMPK-BA) @ AbbVie

Bioanalytical Strategies for Characterization and PK Assessment of Multi-specific Antibodies

Mike Weis, PhD

Director PK/PD Modeler @ Kymera Therapeutics

Pharmacokinetic and Pharmacodynamic Modeling of STAT3 Degraders

Joleen White, PhD

Head of Bioassay Development & Operations @ Bill and Melinda Gates Medical Research Institute

Patient Centric Sampling in the Therapeutic Development Programs

Matt Westfall, PhD

Director, Research & Development @ Inotiv

Targeted High-Resolution Mass Spectrometry: Sensitive & Precise Therapeutic Protein Target Quantification in Any Tissue

Ramola Sane, PhD

Research Investigator @ Bristol-Myers Squibb

Leveraging ADMET Data To Select A Best In Class LPA1 Antagonist

 Liang Jin, PhD

Senior Scientist @ AbbVie

Multi-omics Analysis of Colon Mucosa and Wall from Crohn's Disease Patients

 Brijesh Garg, PhD

Clinical Biomarker/ADA/Bioanalytical @ PepGen

ddPCR Technology in Muscular Dystrophy Research to Quantify Human Skipped/Non-Skipped Transcripts

 Lei Ci, PhD

Associate Scientific Director @ Moderna

ADME and DDI Characterization of a Novel LNP Lipid Excipient

Min Zhao, PhD

Scientist @ Moderna

Qualification for Sars-Cov-2 Neutralization Assay